Blue Jet Healthcare Limited (BLUEJET) Fair Value & Analysis
Healthcare · IN · Market cap ₹91.1B
Fair value as of: Jun 29, 2026
Analysis
Blue Jet Healthcare Limited (BLUEJET) currently trades at ₹527.60, while our model-based Fair Value estimate is ₹263.21 — implying the stock looks roughly 50.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Blue Jet Healthcare Limited (BLUEJET) undervalued?
What is the fair value of BLUEJET?
What is the quality score of BLUEJET?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.